Lineage Cell Therapeutics (United States)
- Research works
- 115 ▼ 28% vs 2018-21
- Citations
- 3.6k 31.6 per fractional work
- Top-10% rate
- 10.1% all institutions 10.0%
- Open access
- 43% world 40%
- International
- 22% world 18%
Not ranked overall: Lineage Cell Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Lineage Cell Therapeutics (United States) work in?
In 2022-now, 53% of research at Lineage Cell Therapeutics (United States) is in Life Sciences, 30% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (44%), Medicine (27%), Immunology and Microbiology (6%). It does 2.7× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 17 fields, with their numbers
- Life Sciences1553.1%
- Health Sciences829.8%
- Medicine827.0%
- Health Professions01.6%
- Dentistry01.2%
- Social Sciences310.6%
- Physical Sciences26.5%
- Engineering12.9%
- Environmental Science12.1%
- Earth and Planetary Sciences00.9%
- Chemistry00.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.3×. Every wedge is a field page.
All 17 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology8.29×12 works
- Immunology and Microbiology5.68×2 works
- Pharmacology, Toxicology and Pharmaceutics3.41×0 works
- Dentistry2.48×0 works
- Medicine1.41×8 works
- Arts and Humanities1.08×1 works
- Psychology0.99×1 works
- Health Professions0.61×0 works
- Earth and Planetary Sciences0.57×0 works
- Neuroscience0.43×0 works
- Environmental Science0.42×1 works
- Chemistry0.38×0 works
- Business, Management and Accounting0.30×0 works
- Agricultural and Biological Sciences0.25×0 works
- Social Sciences0.24×1 works
- Economics, Econometrics and Finance0.22×0 works
- Engineering0.20×1 works
- Biochemistry, Genetics and Molecular Biology 8.3×
- Immunology and Microbiology 5.7×
- Pharmacology, Toxicology and Pharmaceutics 3.4×
- Dentistry 2.5×
- Medicine 1.4×
- Arts and Humanities 1.1×
- Psychology 1.0×
- Health Professions 0.6×
- Earth and Planetary Sciences 0.6×
- Neuroscience 0.4×
- Environmental Science 0.4×
- Chemistry 0.4×
- Business, Management and Accounting 0.3×
- Agricultural and Biological Sciences 0.2×
- Social Sciences 0.2×
- Economics, Econometrics and Finance 0.2×
- Engineering 0.2×
Who are the top researchers at Lineage Cell Therapeutics (United States)?
Ranked on the quality score, Thomas I. Zarembinski, Gascón y Guimbao, Domingo, 1845-1908 and Edward Robert Wassman lead among researchers whose main affiliation is Lineage Cell Therapeutics (United States).
- 1
Thomas I. Zarembinski
United States · #504,079 worldwide 2.2k citations · 36 works
- 2
Gascón y Guimbao, Domingo, 1845-1908
United States · #1,804,318 worldwide 0 citations · 139 works
- 3
Edward Robert Wassman
United States · #1,819,236 worldwide 966 citations · 32 works
- 4
François Binette
United States · #2,352,135 worldwide 2.7k citations · 37 works
- 5
Rena J. Vanzo
United States · #2,464,832 worldwide 1.2k citations · 40 works
- 6
Igor O. Nasonkin
United States · #2,802,676 worldwide 2k citations · 69 works
- 7
Megan M. Martin
United States · #4,762,221 worldwide 625 citations · 60 works
- 8
Hal Sternberg
United States · #5,038,336 worldwide 1.1k citations · 68 works
- 9
Ratnesh Kumar Singh
United States · #5,089,353 worldwide 575 citations · 33 works
Which keywords describe research at Lineage Cell Therapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Gene Expression, Quantitative, Cancer, Data Analysis, Normalization, Glycosylation, Cancer Immunotherapy and Fc Receptors.
- tumor
- Rett Syndrome
- Genetic Mutations
- Chimeric Antigen Receptor
- Brain Development
- Protein Microarrays
- High-Throughput Analysis
- Reference Genes
- Fc Receptors
- Immunotherapy
- Normalization
- Epidemiology
- Quantitative
- Gene Expression
- Cancer
- Data Analysis
- Glycosylation
- Cancer Immunotherapy
- Real-Time PCR
- Therapeutic Antibodies
- Imaging
- Tumor Regression
- CAR T Cells
- Fragile X Syndrome
- PET/CT
- Targeted Therapy
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Gene Expression2▲ 14×5 topics
- Quantitative2▲ 95×2 topics
- Cancer2▲ 5.7×12 topics
- Epidemiology2▲ 1.54×8 topics
- Data Analysis2▲ 20×2 topics
- Normalization2▲ 107×2 topics
- Glycosylation1▲ 45×2 topics
- Immunotherapy1▲ 6.8×5 topics
- Cancer Immunotherapy1▲ 32×2 topics
- Fc Receptors1▲ 88×1 topic
- Real-Time PCR1▲ 188×1 topic
- Reference Genes1▲ 188×1 topic
- Therapeutic Antibodies1▲ 69×1 topic
- High-Throughput Analysis1▲ 117×1 topic
- Imaging1▲ 17×2 topics
- Protein Microarrays1▲ 239×1 topic
- Tumor Regression1▲ 36×2 topics
- Brain Development1▲ 21×2 topics
- CAR T Cells1▲ 50×1 topic
- Chimeric Antigen Receptor1▲ 50×1 topic
- Fragile X Syndrome1▲ 132×1 topic
- Genetic Mutations1▲ 8.6×2 topics
- PET/CT1▲ 66×1 topic
- Rett Syndrome1▲ 132×1 topic
- Targeted Therapy1▲ 16×3 topics
- tumor1▲ 66×1 topic
Which research topics does Lineage Cell Therapeutics (United States) publish most on?
By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Molecular Biology Techniques and Applications, Advanced Biosensing Techniques and Applications and Genetics and Neurodevelopmental Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 2 Molecular Biology Techniques and Applications Molecular Biology 1 works
- 3 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
- 4 Genetics and Neurodevelopmental Disorders Genetics 1 works
- 5 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 6 CAR-T cell therapy research Oncology 1 works
- 7 Cancer Genomics and Diagnostics Cancer Research 1 works
- 8 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 9 Reading and Literacy Development Developmental and Educational Psychology 1 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Lineage Cell Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 28% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Lineage Cell Therapeutics (United States) as a percentage of every work published that year, 0.00022% in 2024.
Fractional works of Lineage Cell Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Carlsbad
- Ionis Pharmaceuticals (United States)
- Jones Institute
- Gemological Institute of America
- Viasat (United States)
- Flometrics (United States)
- Neuroscience Education Institute
- Structural Analytics (United States)
- Advanced Brain Monitoring (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Lineage Cell Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.